Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jake R Morgan

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Journal of Substance Abuse Treatment|March 23, 2020
Opioid overdose and inpatient care for substance use disorder care in MassachusettsJake R Morgan, Jianing Wang, Joshua A Barocas, et al.
Journal of Addiction Medicine|September 28, 2023
Establishing a Protocol for Determining the Costs of an Integrated Set of Evidence-based Practices Aimed at Reducing Opioid Overdose DeathsYjuliana Tin, Mathieu Castry, Rachel Bowers-Sword, et al.
Drug and Alcohol Dependence|December 5, 2021
Broadening access to naloxone: Community predictors of standing order naloxone distribution in MassachusettsAvik Chatterjee, Shapei Yan, Ziming Xuan, et al.
American Journal of Public Health|October 26, 2018
Estimated Prevalence of Opioid Use Disorder in Massachusetts, 2011-2015: A Capture-Recapture AnalysisJoshua A Barocas, Laura F White, Jianing Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2019
Cost-effectiveness of Hepatitis C Virus Treatment Models for People Who Inject Drugs in Opioid Agonist Treatment ProgramsSarah Gutkind, Bruce R Schackman, Jake R Morgan, et al.
Drug and Alcohol Dependence|February 26, 2018
Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programsBruce R Schackman, Sarah Gutkind, Jake R Morgan, et al.
Drug and Alcohol Dependence|July 19, 2025
A geospatial analysis of naloxone distribution patterns in the Massachusetts overdose education and naloxone distribution program (MA OEND)Timothy W Levengood, Leah C Shaw, Xiao Zang, et al.
The International Journal on Drug Policy|September 5, 2021
Targeting community-based naloxone distribution using opioid overdose death rates: A descriptive analysis of naloxone rescue kits and opioid overdose deaths in Massachusetts and Rhode IslandXiao Zang, Alexandria Macmadu, Maxwell S Krieger, et al.
Addiction (Abingdon, England)|March 22, 2022
Population-level impact of initiating pharmacotherapy and linking to care people with opioid use disorder at inpatient medically managed withdrawal programs: an effectiveness and cost-effectiveness analysisAlexandra Savinkina, Rajapaksha W M A Madushani, Golnaz Eftekhari Yazdi, et al.
Drug and Alcohol Dependence|October 29, 2022
Evaluating equity in community-based naloxone access among racial/ethnic groups in MassachusettsShayla Nolen, Xiao Zang, Avik Chatterjee, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Journal of Substance Abuse Treatment|March 23, 2020
Opioid overdose and inpatient care for substance use disorder care in MassachusettsJake R Morgan, Jianing Wang, Joshua A Barocas, et al.
Journal of Addiction Medicine|September 28, 2023
Establishing a Protocol for Determining the Costs of an Integrated Set of Evidence-based Practices Aimed at Reducing Opioid Overdose DeathsYjuliana Tin, Mathieu Castry, Rachel Bowers-Sword, et al.
Drug and Alcohol Dependence|December 5, 2021
Broadening access to naloxone: Community predictors of standing order naloxone distribution in MassachusettsAvik Chatterjee, Shapei Yan, Ziming Xuan, et al.
American Journal of Public Health|October 26, 2018
Estimated Prevalence of Opioid Use Disorder in Massachusetts, 2011-2015: A Capture-Recapture AnalysisJoshua A Barocas, Laura F White, Jianing Wang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2019
Cost-effectiveness of Hepatitis C Virus Treatment Models for People Who Inject Drugs in Opioid Agonist Treatment ProgramsSarah Gutkind, Bruce R Schackman, Jake R Morgan, et al.
Drug and Alcohol Dependence|February 26, 2018
Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programsBruce R Schackman, Sarah Gutkind, Jake R Morgan, et al.
Drug and Alcohol Dependence|July 19, 2025
A geospatial analysis of naloxone distribution patterns in the Massachusetts overdose education and naloxone distribution program (MA OEND)Timothy W Levengood, Leah C Shaw, Xiao Zang, et al.
The International Journal on Drug Policy|September 5, 2021
Targeting community-based naloxone distribution using opioid overdose death rates: A descriptive analysis of naloxone rescue kits and opioid overdose deaths in Massachusetts and Rhode IslandXiao Zang, Alexandria Macmadu, Maxwell S Krieger, et al.
Addiction (Abingdon, England)|March 22, 2022
Population-level impact of initiating pharmacotherapy and linking to care people with opioid use disorder at inpatient medically managed withdrawal programs: an effectiveness and cost-effectiveness analysisAlexandra Savinkina, Rajapaksha W M A Madushani, Golnaz Eftekhari Yazdi, et al.
Drug and Alcohol Dependence|October 29, 2022
Evaluating equity in community-based naloxone access among racial/ethnic groups in MassachusettsShayla Nolen, Xiao Zang, Avik Chatterjee, et al.
Pageof 8